Aspirin prevents NF-κ B activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Objective In previous studies using oesophageal squamous cells from patients with Barrett's oesophagus (normal oesophageal squamous (NES)-B cells) and from patients without Barrett's oesophagus (NES-G cells), we showed that acid and bile salts induced caudal-related homeobox transcription factor 2 (CDX2) expression only in NES-B cells. CDX2, a transcription factor required to form intestinal epithelium, is a target of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κ B) signalling, which can be inhibited by aspirin. We explored mechanisms underlying differences between NES-B and NES-G cells in CDX2 expression and effects of aspirin on that CDX2 expression. Design We exposed NES-B and NES-G cells to acid and bile salts, with and without aspirin, and evaluated effects on Iκ B-NF-κ B-PKAc complex activation, p65 NF-κ B subunit function, and CDX2 expression. Results In both NES-B and NES-G cells, acid and bile salts activated nicotinamide adenine dinucleotide phosphate oxidase to generate H 2 O 2, which activated the Iκ B-NF-κ B-PKAc complex. NES-B cells exhibited higher levels of phosphorylated Iκ B and p65 and greater NF-κ B transcriptional activity than NES-G cells, indicating greater Iκ B-NF-κ B-PKAc complex activation by acid and bile salts in NES-B cells, and p65 siRNA prevented their increased expression of CDX2. Aspirin blocked Iκ B phosphorylation, p65 nuclear translocation, CDX2 promoter activation and CDX2 expression induced by acid and bile salts in NES-B cells. Conclusions Differences between NES-B and NES-G cells in NF-κ B activation by acid and bile salts can account for their differences in CDX2 expression, and their CDX2 expression can be blocked by aspirin. These findings might explain why some patients with GORD develop Barrett's oesophagus while others do not, and why aspirin might protect against development of Barrett's oesophagus.

Original languageEnglish (US)
Pages (from-to)606-615
Number of pages10
JournalGut
Volume67
Issue number4
DOIs
StatePublished - Apr 1 2018

Keywords

  • INFLAMMATION
  • OESOPHAGEAL DISEASE
  • OESOPHAGEAL REFLUX

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Aspirin prevents NF-κ B activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus'. Together they form a unique fingerprint.

  • Cite this